Cytek Biosciences, Inc. CTKB Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenue, net by Geography | ||||||
| APAC | $7.75M-12.8% | $13.18M+14.6% | $11.14M+24.7% | $7.87M-12.4% | $8.89M+40.0% | |
| China | $3.6M-32.1% | $6.3M— | $5.3M— | $3.6M— | $5.3M+65.6% | |
| EMEA | $10.77M-6.9% | $19.62M+21.1% | $12.39M-28.1% | $12.31M-10.6% | $11.57M-23.5% | |
| Other | $1.23M-50.0% | $3.72M-29.3% | $1.56M+59.8% | $1.53M+4.4% | $2.47M+21.7% | |
| United States | $24.4M+31.6% | $25.62M+4.5% | $27.2M+11.7% | $23.9M+6.7% | $18.54M-13.4% | |
| Total by Geography | ||||||
| APAC | $9.52M+2.5% | $9.61M+3.3% | $9.62M+3.4% | $9.52M+5.7% | $9.28M+0.4% | |
| EMEA | $436K+3.3% | $425K-2.3% | $446K-18.6% | $471K+12.1% | $422K+1.7% | |
| United States | $10.52M+29.3% | $7.98M-3.0% | $7.98M-7.8% | $8.37M-3.7% | $8.13M-5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cytek Biosciences, Inc. break its business down?
- Cytek Biosciences, Inc. (CTKB) reports total revenue, net by geography across 5 parts — APAC, China, EMEA, Other and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytek Biosciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytek Biosciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
